Last Updated: 08/08/2025
Research and development of a next-generation vaccine that can treat all stages of falciparum malaria
Objectives
*Original title and text were machine translated from Japanese
This project aims to develop the world’s first all-stage vaccine for falciparum malaria.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
The current falciparum malaria vaccines, RTS,S and R21, focus only on preventing infection, and have the weakness of being ineffective against parasites that have successfully invaded the liver. In this study, we will develop a vaccine that can comprehensively address the entire malaria life cycle, including preventing infection, preventing onset and preventing transmission, and evaluate its effectiveness in a mouse model. All experiments will be completed within three years at the research institute, and a paper will be written.
External reference
Themes
Date
Apr 2025 — Mar 2028
Total Project Funding
$31,748
Funding Details
Project Site
Related Resources
